Tiziana Life Sciences has shared positive three-month neuroimaging scores in non-active secondary progressive multiple sclerosis (na-SPMS) patients receiving intranasal foralumab. Affecting ...

Of course social media has its downside. But online platforms are a powerful tool for women in medicine in terms of forming ...

Bristol Myers Squibb (BMS) and Repertoire Immune Medicines have entered into a multi-year strategic collaboration worth over $1.8bn to develop tolerising vaccines for up to three autoimmune diseases.

Pfizer’s Beqvez (fidanacogene elaparvovec-dzkt) has been approved by the US Food and Drug Administration (FDA) to treat ...

AstraZeneca’s (AZ) AKT inhibitor Truqap (capivasertib) in combination with its endocrine therapy Faslodex (fulvestrant) has ...

Change is an essential aspect of any business, and learning to manage it effectively will be key for long-term success. Getting your team on board with change and digital transformation requires ...

Johnson & Johnson’s (J&J) Rybrevant (amivantamab) in combination with chemotherapy, has been recommended by the European ...

Regeneron Pharmaceuticals and Mammoth Biosciences have announced a collaboration aimed at developing CRISPR-based gene ...

Up to 40% of patients who have undergone definitive prostate cancer treatment will experience biochemical recurrence within ...

Biogen has announced that Tofidence (tocilizumab-bavi), a biosimilar referencing Roche’s RoActemra, has been recommended by ...